Non-Sterile Outsourcing Market, Share & Trends Analysis Report, By Dosage form (Oral, Ear & Eye, Nasal, Topical, Parenteral), By Application (Human Medication, Nutraceuticals, Cosmetics, Medical Devices, Veterinary Health), By Region, and Segment Forecasts, 2024-2031

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Non-Sterile Outsourcing Market Snapshot Chapter 4. Global Non-Sterile Outsourcing Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. Competitive Landscape & Market Share Analysis 4.8. Impact of Covid-19 Analysis Chapter 5. Market Segmentation 1: by Dosage Form Estimates & Trend Analysis 5.1. by Dosage Form & Market Share, 2019 & 2031 5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Dosage Form: 5.2.1. Oral 5.2.1.1. Mixtures 5.2.1.2. Linctures 5.2.1.3. Syrups 5.2.1.4. Elixirs 5.2.1.5. Mouth Washes/Gargles 5.2.1.6. Drops 5.2.2. Ear & Eye 5.2.2.1. Drops 5.2.2.2. Lotions 5.2.3. Nasal 5.2.3.1. Drops 5.2.3.2. Sprays 5.2.4. Topical 5.2.4.1. Gel 5.2.4.2. Cream 5.2.5. Parenteral Chapter 6. Market Segmentation 2: by End User Estimates & Trend Analysis 6.1. by End User & Market Share, 2019 & 2031 6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End User: 6.2.1. Pharmaceutical Companies 6.2.1.1. Human 6.2.1.2. Veterinary 6.2.2. Cosmeceuticals Companies 6.2.3. Nutraceutical Companies 6.2.4. Medical Device Manufacturers Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis 7.1. by Application & Market Share, 2019 & 2031 7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application: 7.2.1. Human Medication 7.2.2. Nutraceuticals 7.2.3. Cosmetics 7.2.4. Medical Devices 7.2.5. Veterinary Health Chapter 8. Non-Sterile Outsourcing Market Segmentation 4: Regional Estimates & Trend Analysis 8.1. North America 8.1.1. North America Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Dosage Form, 2024-2031 8.1.2. North America Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031 8.1.3. North America Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031 8.1.4. North America Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031 8.2. Europe 8.2.1. Europe Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Dosage Form, 2024-2031 8.2.2. Europe Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031 8.2.3. Europe Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031 8.2.4. Europe Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031 8.3. Asia Pacific 8.3.1. Asia Pacific Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Dosage Form, 2024-2031 8.3.2. Asia Pacific Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031 8.3.3. Asia-Pacific Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031 8.3.4. Asia Pacific Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031 8.4. Latin America 8.4.1. Latin America Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Dosage Form, 2024-2031 8.4.2. Latin America Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031 8.4.3. Latin America Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031 8.4.4. Latin America Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031 8.5. Middle East & Africa 8.5.1. Middle East & Africa Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Dosage Form, 2024-2031 8.5.2. Middle East & Africa Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031 8.5.3. Middle East & Africa Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031 8.5.4. Middle East & Africa Non-Sterile Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031 Chapter 9. Competitive Landscape 9.1. Major Mergers and Acquisitions/Strategic Alliances 9.2. Company Profiles 9.2.1. AbbVie Pharmaceutical Contract Manufacturing 9.2.2. Aenova Group 9.2.3. APPCO Pharmaceutical Corporation 9.2.4. Atral Pharmaceutical 9.2.5. Aurigene Pharmaceutical Services (Dr. Reddy's) 9.2.6. Biological E. Ltd. 9.2.7. BioPlus Life Sciences 9.2.8. Bora Pharmaceuticals 9.2.9. Cambrex Corporation 9.2.10. COC Farmaceutici 9.2.11. Contract Pharmaceuticals Limited (CPL) 9.2.12. DPT Laboratories, Ltd. 9.2.13. Eurofins 9.2.14. JGL d.d. 9.2.15. Mikart 9.2.16. PharmaVision (Vizyon Holding) 9.2.17. Pierre Fabre 9.2.18. TriRx Pharmaceutical Services 9.2.19. UI Pharmaceuticals 9.2.20. Wasdell Group 9.2.21. Other Prominent Players